Prognostic Value of Systemic Inflammation and Oxidative Stress Indices (SIRI, SII, NASII, HSS, and HALP) for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage: A Retrospective Cohort Study
This retrospective cohort study found that the Systemic Inflammation Response Index (SIRI) and the novel Neutrophil-Amplified Systemic Immune-Inflammation Index (NASII), derived from routine admission blood tests, are associated with in-hospital mortality in spontaneous intracerebral hemorrhage independent of age and sex, though their predictive value is substantially attenuated when adjusted for neurological severity (admission GCS), suggesting they serve as hypothesis-generating markers requiring prospective validation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a sudden bleed occurs inside the brain, the body's reaction is often as dangerous as the injury itself. This condition, known as spontaneous intracerebral hemorrhage, strikes without warning and carries a grim outlook, with nearly one-third of patients passing away before leaving the hospital. While doctors have long understood that the physical size and location of the blood clot are critical, a growing body of research suggests that the body's own defense systems play a massive role in the outcome. When the brain is injured, it triggers a chain reaction of inflammation and oxidative stress, where immune cells flood the area and release chemicals that can damage healthy tissue. Scientists have begun looking for simple clues in the blood that might reveal how fierce this internal storm is, hoping to find a way to predict who is most at risk before the damage becomes irreversible.
In a recent study conducted at a major hospital in Gaziantep, Turkey, researchers set out to test five different blood-based tools designed to measure this systemic inflammation and stress. They focused on a group of 200 adults who had been admitted with a confirmed brain bleed. Upon arrival, every patient had a standard blood test drawn, which provided the numbers needed to calculate five specific scores. These scores were derived from routine measurements of white blood cells, platelets, hemoglobin, and albumin, all of which are part of a standard check-up. The researchers wanted to see if these calculated numbers could predict which patients would survive their hospital stay and which would not, potentially offering a quick, low-cost way to assess severity alongside traditional methods.
The team examined how well each of these five indices performed. One score, known as the Systemic Inflammation Response Index, or SIRI, stood out as the most promising. This index combines counts of neutrophils, monocytes, and lymphocytes to gauge the intensity of the body's inflammatory response. The study found that patients who did not survive had significantly higher SIRI scores upon admission compared to those who recovered. When the researchers adjusted their analysis to account for age and sex, the SIRI score remained a strong independent predictor of death. Another new index, called the Neutrophil-Amplified Systemic Immune-Inflammation Index, or NASII, showed a similar trend, though its ability to predict outcomes on its own was slightly less robust than SIRI.
However, the story became more nuanced when the researchers looked at the patients' neurological status. They found that the blood scores were closely linked to how confused or unconscious a patient was when they arrived, a measure known as the Glasgow Coma Scale. When they added this clinical assessment into their calculations, the independent power of the blood scores faded. This suggests that the inflammation measured by the blood tests is not a separate, hidden danger, but rather a reflection of the same severe brain injury that causes a patient to lose consciousness. In other words, the blood markers tell a story that largely overlaps with what a doctor can already see by checking a patient's level of alertness.
Not every tool the researchers tested proved useful. One score, the Hemoglobin-Albumin-Lymphocyte-Platelet index, which was designed to reflect nutritional and immune health, failed to distinguish between survivors and non-survivors. The data showed that this particular score did not provide any meaningful information about who would die in the hospital. Similarly, a composite score that combined elements of the other indices did not improve predictions beyond what the individual blood markers could already suggest. The study concluded that while the SIRI score is a reliable indicator of the inflammatory burden in these patients, it does not offer a magic bullet for prediction that works independently of a full clinical examination.
The authors emphasize that their findings are a starting point rather than a final solution. The study was conducted at a single hospital with a limited number of patients, and the results need to be confirmed in larger, more diverse groups before they can change how doctors treat brain bleeds. The research highlights that the body's inflammatory response is a significant part of the disease process, but it also shows that the most powerful predictor of survival remains the patient's immediate neurological condition. For now, these blood tests offer a fascinating glimpse into the body's reaction to trauma, but they are best viewed as a supplementary tool that supports, rather than replaces, the careful clinical judgment of medical teams.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.